Shareholder word cloud collage business concept background

Shareholder word cloud collage business concept background

Top 10 Reasons to Buy IVST

1. Channeling for almost 6 months in the $0.15-$0.30 range, IVST is
ready for another breakout. Full size chart: https://tinyurl.com/y9lbw7xr

2. Set to Add $30 Million in Annual Revenue with Pending Acquisition

3. Media Efforts Take Root Ahead of Biotechnology Developments

4. 20% ownership in Stem Vax. StemVax brain tumor vaccine has been
granted patent approval after a nine year filing process

5. First half 2018 revenue growth 55.8%

6. No convertible debts, no warrants or options outstanding

7. Current assets of $877,861; Cash balance of $561,062

8. Winslow Asset Management, the first institutional investor in
Innovest Global, filed showing that they remain a long shareholder

9. OCT Pink Current

10. Shares Outstanding Shares 109M 9/14/18. Float Shares 11.7M 8/16/18

Leave a Reply

Your email address will not be published.Required fields are marked *